Target intelligence / Profile preview

Peptidoglycan transglycosylase complex (GTase)

Target
GTase
Molecular classification
Enzyme, Glycosyltransferase, Membrane protein complex
01

Overview

The peptidoglycan transglycosylation complex is a critical enzymatic assembly responsible for the polymerization of the bacterial cell wall. It facilitates the transfer of the disaccharide-pentapeptide moiety from the membrane-anchored precursor, Lipid II, to the growing glycan chain [1][2]. This essential step is performed by two main groups of enzymes: the transglycosylase domains of bifunctional Class A Penicillin-Binding Proteins (aPBPs) and the SEDS (Shape, Elongation, Division, and Sporulation) family proteins, such as RodA and FtsW [1][4]. Because peptidoglycan is absent in eukaryotic cells, this complex represents a highly selective target for antibiotic development [3]. Direct inhibitors like moenomycin bind to the transglycosylase active site, while glycopeptide antibiotics like vancomycin sequester the substrate to prevent its utilization [3]. Inhibition of this complex compromises the structural integrity of the bacterial cell wall, leading to osmotic lysis and cell death [2]. Sources: [1] Meeske, A. J., et al. (2016) Nature; [2] Sauvage, E., et al. (2008) FEMS Microbiology Reviews; [3] Ostash, B., & Walker, S. (2010) Current Opinion in Chemical Biology; [4] Cho, H., et al. (2016) Nature Communications.

Other names
Peptidoglycan polymeraseGlycosyltransferaseClass A Penicillin-Binding Protein (aPBP)SEDS-PBP complexRodA-PBP2 complexFtsW-PBP3 complexLipid II transglycosylase
02

Mechanism of action

Inhibition of glycan chain elongation by blocking the transfer of disaccharide-pentapeptide units from Lipid II to the growing peptidoglycan polymer, either through direct enzyme inhibition or substrate sequestration.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyBacterial cell divisionCell shape maintenanceGlycan chain elongation
04

Disease associations

Infection
05

Safety considerations

Development of antibiotic resistance (e.g., VRSA, VRE)Nephrotoxicity (associated with certain glycopeptides)Poor oral bioavailability of direct transglycosylase inhibitorsInfusion-related reactions (e.g., Red Man Syndrome)
06

Interacting drugs

Moenomycin A

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Lipid II accumulationBacterial cell lysis ratePeptidoglycan cross-linking density

Beyond the preview

Go deeper on Peptidoglycan transglycosylase complex (GTase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan transglycosylase complex (GTase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call